https://www.selleckchem.com/pr....oducts/wnt-agonist-1
2% vs. 70.6%) than IBC without DLI. Over a median follow-up of 2.0 years, 147 deaths occurred. DLI was not associated with survival or recurrence in multivariable models (all P ≥0.1. For example, among women with stage III disease, hazard ratios (95% confidence intervals) for DLI presence was 1.29 (0.77-2.15) for overall survival, 1.29 (0.56-3.0 for locoregional recurrence, and 1.71 (0.97-3.02) for distant metastasis. Although the extent of tumor emboli in dermal lymphatics may be associated with biological features of IBC, DL
Respect!
Kommentar
Delen
